Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Mylan stock slumps 1.3% after company says voluntary recall will include U.S. EpiPens
Mylan stock slumps 1.3% after company says voluntary recall will include U.S. EpiPens
Mylan stock slumps 1.3% after company says voluntary recall will include U.S. EpiPens
Submitted by
admin
on March 31, 2017 - 10:03pm
Source:
Marketwatch
News Tags:
Mylan Labs
recalls
EpiPens
Headline:
Mylan stock slumps 1.3% after company says voluntary recall will include U.S. EpiPens
Do Not Allow Advertisers to Use My Personal information
